
Mounjaro hits India, Bengal's Diamond Harbour Model, and Waqf Bill faces heat
3 Things
00:00
Intro
This chapter covers the launch of the weight loss drug Mounjaro in India, highlighting its unique mechanisms and advantages over competitors like Ozempic. It also examines potential side effects and the broader implications for obesity treatment.
Transcript
Play full episode